Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems

Journal of Controlled Release

Volumn 122, Issue 3, 2007, Pages 287-296

  Nie, Ting ^a   Baldwin, Aaron ^a   Yamaguchi, Nori ^a   Kiick, Kristi L ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Controlled release; Growth factor; Heparin; Hydrogel; Protein release

Indexed keywords

CONTROLLED DRUG DELIVERY; FIBROBLASTS; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYETHYLENE GLYCOLS; SYNTHESIS (CHEMICAL);

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; IMMUNOCHEMICAL ASSAYS;

HYDROGELS;

BASIC FIBROBLAST GROWTH FACTOR; CARBOXYLIC ACID; GROWTH FACTOR; HEPARIN; MALEIMIDE; POLOXAMER; POLYMER; THIOL;

ARTICLE; CATALYST; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG DELIVERY SYSTEM; FLOW MEASUREMENT; GELATION; HYDROGEL; IMMUNOCHEMISTRY; OSCILLATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; REACTION TIME; SYNTHESIS; YOUNG MODULUS;

BIOCOMPATIBLE MATERIALS; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HUMANS; HYDROGELS; MALEIMIDES; RECOMBINANT PROTEINS;

EID: 34548637042     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.04.019     Document Type: Article

References (49)

1. Drury J.L., and Mooney D.J. Hydrogels for tissue engineering: scaffold design variables. Biomaterials 24 (2003) 4337-4351
2. Nguyen K.T., and West J.L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 23 (2002) 4307-4314
3. Brandl F., Sommer F., and Goepferich A. Rational design of hydrogels for tissue engineering: Impact of physical factors on cell behavior. Biomaterials 28 (2007) 134-146
4. Lee K.Y., and Mooney D.J. Hydrogels for tissue engineering. Chem. Rev. 101 (2001) 1869-1879
5. Capila I., and Linhardt R.J. Heparin-protein interactions. Angew. Chem. Int. Ed. 41 (2002) 390-412
6. Fromm J.R., Hileman R.E., Caldwell E.E.O., Weiler J.M., and Linhardt R.J. Pattern and spacing of basic amino acids in heparin binding sites. Arch. Biochem. Biophys. 343 1 (1997) 92-100
7. Kamei K., Wu X.F., Xu X.Y., Minami K., Huy N.T., Takano R., Kato H., and Hara S. The analysis of heparin-protein interactions using evanescent wave biosensor with regioselectively desulfated heparins as the ligands. Anal. Biochem. 295 2 (2001) 203-213
8. Fromm J.R., Hileman R.E., Weiler J.M., and Linhardt R.J. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Arch. Biochem. Biophys. 346 2 (1997) 252-262
9. Nugent M., and Iozzo R. Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32 (2000) 115-120
10. Sakiyama-Elbert S.E., and Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Control. Release 65 3 (2000) 389-402
11. Zhang L., Furst E.M., and Kiick K.L. Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions. J. Control. Release 114 2 (2006) 130-142
12. Cai S., Liu Y., Shu X.Z., and Prestwich G.D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 26 (2005) 6054-6067
13. Tae G.Y., Scatena1 M., Stayton P., and Hoffman A. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J. Biomater. Sci., Polym. Ed. 17 (2006) 187-197
14. Nakamura M., Ishihara K., Obara, Masuoka K., Ishizuka T., Kanatani Y., Takase B., Matsui T., Hattori H., Sato T., Kariya Y., and Maehara1 T. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization. J. Biomed. Mater. Res., Part A 78A (2006) 364-337
15. Wissink M.J.B., Beernink R., Pieper J.S., Poot A.A., Engbers G.H.M., Beugeling T., van Aken W.G., and Feijen J. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 22 (2001) 151-163
16. Liu L.S., Ng C.K., Thompson A.Y., Poser J.W., and Spiro R.C. Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2). J. Biomed. Mater. Res. 62 (2002) 128-135
17. Chinen N., Tanihara M., Nakagawa M., Shinozaki K., Yamamoto E., Mizushima Y., and Suzuki Y. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. J. Biomed. Mater. Res., Part A 67A (2003) 61-68
18. Yamaguchi N., and Kiick K.L. Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels. Biomacromolecules 6 (2005) 1921-1930
19. Seal B.L., and Panitch A. Viscoelastic behavior of environmentally sensitive biomimetic polymer matrices. Macromolecules 39 6 (2006) 2268--227
20. Seal B.L., and Panitch A. Physical polymer matrices based on affinity interactions between peptides and polysaccharides. Biomacromolecules 4 (2003) 1572-1582
21. Yamaguchi N., Chae B., Zhang L., Kiick K.L., and Furst E.M. Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels. Biomacromolecules 6 (2005) 1931-1940
22. Yamaguchi N., Zhang L., Chae B., Palla C.S., Furst E.M., and Kiick K.L. Growth factor mediated assembly of cell receptor-responsive hydrogels. J. Am. Chem. Soc. 129 (2007) 3040-3041
23. Zetter B. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49 (1998) 407-424
24. Hermanson G.T. Bioconjugate Techniques (1996), Academic Press, New York
25. Nadkarni V.D., Pervin A., and Linhardt R.J. Directional immobilization of heparin onto beaded supports. Anal. Biochem. 222 (1994) 59-67
26. Osmond R.I., Kett W.C., Skett S.E., and Coombe D.R. Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization. Anal. Biochem. 310 (2002) 199-207
27. Olde Daminka L.H.H., Dijkstraa P.J., van Luyn M.J.A., van Wachem P.B., Nieuwenhuis P., and Feijen J. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 17 8 (1996) 765-773
28. Keller O., and Rudinger J. Preparation and some properties of maleimido acids and maleoyl derivatives of peptides. Helv. Chim. Acta 58 (1975) 531-541
29. Hashida S., Imagawa M., Inoue S., Ruan K.H., and Ishikawa E. More useful maleimide compounds for the conjugation of Fab' to horseradish peroxidase through thiol groups in the hinge. J. Appl. Biochem. 6 1-2 (1984) 56-63
30. Hosoda H., Fukuda K., and Gotoh Y. Enzyme labeling in steroid enzyme immunoassays. Comparison of the p-nitrophenyl ester and N-succinimidyl ester methods. Chem. Pharm. Bull. (Tokyo) 39 9 (1991) 2373-2377
31. Hooftman G., Herman S., and Schacht E. Review: poly(ethylene glycol)s with reactive endgroups. II. Practical consideration for the preparation of protein-PEG conjugates. J. Bioact. Compat. Polym. 11 (1996) 135-159
32. Sawhney A.S., and Pathak C.P. J.A. Hubbell Bioerodible hydrogels based on photopolymerized poly (ethylene glycol)-co-poly (α-hydroxy acid) diacrylate macromers. Macromolecules 26 (1993) 581-583
33. Elbert D.L., and Hubbell J.A. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules 2 (2001) 430-441
34. Elbert D.L., Pratt A.B., Lutolf M.P., Halstenberg S., and Hubbell J.A. Protein delivery from materials formed by self-selective conjugate addition reactions. J. Control. Release 76 (2002) 11-25
35. Andreopoulos F.M., Deible C.R., Stauffer M.T., Weber S.G., Wagner W.R., Beckman E.J., et al. Photoscissable hydrogel synthesis via rapid photopolymerization of novel PEG-based polymers in the absence of photoinitiators. J. Am. Chem. Soc. 118 (1996) 6235-6240
36. Williams C.G., Kim T.K., Taboas A., Malik A., and Manson P. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng. 9 4 (2003) 679-689
37. J.M. Harris, A. Kozlowski, Poly(ethylene glycol) derivatives with proximal reactive groups, US Patent: 6, 664, 331, December 16, 2003.
38. Kirpotin D., Park J.W., Hong K., Zalipsky S., Li W., Carter P., Benz C., and Papahadjopoulos D. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 36 (1997) 66-75
39. Maruyama K., Takahashi N., Tagawa T., Nagaike K., and Iwatsuru M. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett. 413 (1997) 177-180
40. Baskar G., Venkatesan S., Dhathathreyan A., and Mandal A. Two-Dimensional Surface Properties of 2-Methoxy Ethyl Oleate at the Air/Water Interface. J. Am. Oil Chem. Soc. 76 7 (1999) 853-858
41. Schoenmakers R.G., van de Wetering P., Elbert D.L., and Hubbell J.A. The effect of the linker on the hydrolysis rate of drug-linked ester bonds. J. Control. Release 95 (2004) 291-300
42. van de Wetering P., Metters A.T., Schoenmakers R.G., and Hubbell J.A. Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. J. Control. Release 102 (2005) 619-627
43. Matsuda T., and Magoshi T. Preparation of vinylated polysaccharides and photofabrication of tubular scaffolds as potential use in tissue engineering. Biomacromolecules 3 (2002) 942-950
44. Alexandridis P., and Hatton T.A. Poly(ethylene oxide)-poly(propylene oxide)-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloid. Surf., A 96 (1995) 1-46
45. Gajewiak J., Cai S., Shu X.Z., and Prestwich G.D. aminooxy pluronics: synthesis and preparation of glycosaminoglycan adducts. Biomacromolecules 7 6 (2006) 1781-1789
46. Saltzman W.M. Tissue engineering: engineering principles for the design of replacement organs and tissues (2004), Oxford University Press, US 121
47. Wissink M.J.B., Beernink R., Poot A.A., Engbers G.H.M., Beugeling T., and van Aken W.G. J. Feijen. J. Control. Release 64 (2000) 103-114
48. Pikea D.B., Cai S., Pomraninga K.R., Firpoc M.A., Fisher R.J., Shub X.Z., Prestwich G.D., and Peattie R.A. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27 (2006) 5242-5251
49. Eriksson A.E., Cousens L.S., Weaver L.H., and Matthews B.W. Three dimensional structure of human basic fibroblast growth factor. Proc. Natl. Acad. Sci. 88 (1991) 3441-3445